Skip to main content

Rheumatoid Arthritis

      Nice data from the OTIS Autoimmune Disease in Pregnancy Project re: certolizumab-exposed pregnancies:
      - spontaneous loss
      5 months ago
      Nice data from the OTIS Autoimmune Disease in Pregnancy Project re: certolizumab-exposed pregnancies: - spontaneous loss rate comparable to non-disease controls - no stillbirths - preterm similar to disease controls Plenty positive for CZP in pregnancy! #ACR24 ABST0805 @RheumNow https://t.co/XCRYsioxC0
      A study exploring the benefits of treating RA patients to remission after achieving low disease activity (LDA).
      Key find
      A study exploring the benefits of treating RA patients to remission after achieving low disease activity (LDA). Key findings: - Among patients initially at LDA, achieving remission (CDAI ≤2.8) led to significantly better functional outcomes and reduced durable medical equipment… https://t.co/SNPKlRieur https://t.co/YIQNMf3Oap
      I have no doubt many of our RA patients will take GLP-1 agonists in the future.
      Here's some data @UCLA showing significa
      5 months ago
      I have no doubt many of our RA patients will take GLP-1 agonists in the future. Here's some data @UCLA showing significant differences in not just body weight and HbA1c, but pain. Will be fascinating to see what it does for grumbling disease activity! #ACR24 ABST2259 @RheumNow https://t.co/HdOPACEo3A
      What is #healthliteracy? Why is it important for our patients with #RMDs?

      Come to poster 1913 today at #ACR24 to find o
      5 months ago
      What is #healthliteracy? Why is it important for our patients with #RMDs? Come to poster 1913 today at #ACR24 to find out about health literacy & outcomes in #InflammatoryArthritis For more information on this important topic, read my article @RheumNow https://t.co/llWs5aYtpK
      The increased risk of cardiovascular disease in patients with rheumatoid arthritis has long been known (1). The association between increased levels of inflammation in rheumatoid arthritis and…
      Instead of just JAKi, why don't we look at all our RA meds and MACE risk

      FAERS data & reporting odds ratios here: a
      5 months ago
      Instead of just JAKi, why don't we look at all our RA meds and MACE risk FAERS data & reporting odds ratios here: all the caveats of voluntary reporting, so don't put too much weight, but... prednisone. Don't forget pred is really not great for MACE! #ACR24 ABST1981 @RheumNow https://t.co/L9SlPZF2Jd
      "There's an app for that"
      but is it enough?

      US informatics national survey 2017-18:
      Rheum pts with digital health tools
      5 months ago
      "There's an app for that" but is it enough? US informatics national survey 2017-18: Rheum pts with digital health tools weren't any healthier living than those without (maybe helps exercise) It might be a conversation starter, but it's only an adjunct #ACR24 ABST1929 @RheumNow https://t.co/EZpSwm0zuP
      Always looking for cancer/CV signals from JAKi in big observational datasets w extensive JAKi usenationwide 🇯🇵 c
      5 months ago

      Always looking for cancer/CV signals from JAKi in big observational datasets w extensive JAKi use nationwide 🇯🇵 claims data RA pts n=52k (JAKi n=4.3k) Cancer with JAKi vs TNFi: aHR 2.2 (esp lung, lymphoma) This is a problem. Watch these data. #ACR24 ABST1336 @RheumNow #ACRBest https://t.co/vsnT46De6T

      Should you worry about giving TNFi to RA pts after a cancer diagnosis?

      Medicare data with colorectal, lung, prostate Ca
      5 months ago
      Should you worry about giving TNFi to RA pts after a cancer diagnosis? Medicare data with colorectal, lung, prostate Ca: TNFi pts survival no worse (numerically better) than csDMARDs Cancer pts deserve good RA treatment! #ACR24 ABST0202 Suarez-Almazor @MDAndersonNews @RheumNow https://t.co/w58MNqRt1T
      ×